🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Capsule(s) Serving Size
60 Servings
Fat/Fatty Acid Product Type
100% Evidence Coverage

Supplement Facts — Evidence Check

1000 mg
📊 Market median: 750.0mg (447 products) 📚 388 studies (Tier A: 18, B: 204)
This product: 1000mg UL 3000mg

Other Ingredients

Vegetable Capsule natural Lemon Oil

Label Claims — Verification

Nutrient
All Other
Structure/Function
All Other (99% of products) Structure/Function (86% of products) Nutrient (79% of products) Qualified Health (13% of products) Approved Health (2% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Recommendation: Take one capsule with a meal 2 times daily.

⚠️ Warnings & Precautions

This bottle was sealed for your protection. Do not use if inner seal is missing or damaged.

🧪 Formulation Notes

1000 mg soft gel capsules

Omega-3 is a natural fish lipid concentrate containing essential fatty acids that are not synthesized by the body and must be obtained through diet or supplementation. Providing 380 mg EPA/ 190 mg DHA per capsule, Omega-3 supports cardiovascular function, brain health, memory and cognition.

May promote healthy circulatory function.

Synergy uses natural source materials that are subject to color variation.

Additional Information

Made in U.S.A.

Product Details

UPC / SKU 3 30748 92051 7
DSLD Entry Date 2020-04-23
Product Type Fat/Fatty Acid
Form Softgel Capsule
Brand Synergy
DSLD ID 217196
Data Updated 2026-04-11

Research Evidence

495 Research Sources
56 Avg Quality Score
222 Meta Analysis
104 Clinical Trial
72 Rct
69 Systematic Review
11 Guideline
5 Cochrane Review
5 Regulatory Source
3 Narrative Review
1 Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
View all evidence for Omega 3 →

Compare Similar Products

View all Omega 3 products →